Company / Interest Expense per Share
Seres Therapeutics, Inc. Interest Expense per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.29
FY2025
5-year range
$0.01 / $0.29
FY2021-FY2025
Trend
+1127.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share changed +1128% YoY in FY2025, a notable deviation from the 6-year average annual change of +335%.
Based on SEC 10-K filings.
0.29 in FY2025 with a 5-year CAGR of +109.0%.
Increased from $0.03 to $0.29 over the past 3 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +107.7%
- 5-Year CAGR
- +109.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, interest expense per share increased 1127.7% year-over-year.
- Lowest interest expense per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.18 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.29 | +1127.7% |
| FY2023 | $0.02 | -27.0% |
| FY2022 | $0.03 | +479.7% |
| FY2021 | $0.01 | -23.3% |
| FY2020 | $0.01 | -41.6% |
| FY2019 | $0.01 | - |
| FY2018 | - | - |
| FY2017 | $0.00 | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 24, 2026